Hôpital Franco-Britannique — Levallois-Perret

Public research footprint of Hôpital Franco-Britannique, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Colorectal Cancer · Triple-Negative Breast Cancer · HER2-(Ultra)Low Expressing Breast Cancer · Metastatic Pancreatic Adenocarcinoma

Recently updated registry entries

NCT06393374 — Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… (Recruiting)
NCT06078384 — Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in… (Recruiting)
NCT05945732 — DESTINY Breast Respond HER2-(Ultra)Low Europe (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hôpital Franco-Britannique?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.